International Standard
ISO 24190:2023
Biotechnology — Analytical methods — Risk-based approach for method selection and validation for rapid microbial detection in bioprocesses
Reference number
ISO 24190:2023
Edition 1
2023-05
International Standard
Read sample
ISO 24190:2023
78060
Published (Edition 1, 2023)

ISO 24190:2023

ISO 24190:2023
78060
Language
Format
CHF 173
Convert Swiss francs (CHF) to your currency

Abstract

This document provides guidance, a framework and a risk-based approach for the selection and validation of methods for rapid microbial detection in cellular therapeutic product manufacturing.

This document provides a flexible risk-based framework for the detection of microbial contamination in cellular therapeutic products and cellular intermediates.

This document provides general requirements and risks associated with cellular therapeutic product manufacturing, with flexibility to address differences in specific manufacturing processes of each unique cellular therapeutic product.

This document primarily addresses sterility testing in cellular therapeutic product manufacturing. This document is applicable to other cell-derived therapeutic product manufacturing.

This document focuses on rapid microbial test methods (RMTMs) used for both in-process and final product testing.

Viral testing in cellular therapeutic product manufacturing is not included in this document.

General information

  •  : Published
     : 2023-05
    : International Standard published [60.60]
  •  : 1
     : 44
  • ISO/TC 276
    07.080 
  • RSS updates

Got a question?

Check out our FAQs

Customer care
+41 22 749 08 88

Opening hours:
Monday to Friday - 09:00-12:00, 14:00-17:00 (UTC+1)